Skip to main content

D. E. Shaw & Co., Inc.

Position in OGN — Organon & Co.

CIK 1009207 New York, NY

Position in OGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,731,915
-$6,108,950 QoQ
Shares Held
718,753
-72.8% QoQ
Ownership
0.274%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#49
of 626 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OGN Over Time

Shares Held

Position Value (USD)

Derivatives in OGN

reported options exposure · as of Jun 30, 2026
CallValue
$238,304
CallShares
17,600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $2,890,989,313 across 13 Drug Manufacturers - General names. OGN ranks #13 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OGN

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,731,915 718,753
2026-06-30 $238,304 17,600
2026-03-31 $15,840,865 2,644,552
2026-03-31 $105,424 17,600
2025-12-31 $24,282,810 3,386,724
2025-12-31 $126,192 17,600
2025-09-30 $187,968 17,600
2025-09-30 $5,242,384 490,860
2024-12-31 $572,928 38,400
2024-09-30 $734,592 38,400
2024-09-30 $2,687,496 140,486
2024-06-30 $794,880 38,400
2024-03-31 $721,920 38,400
2023-12-31 $3,437,728 238,400
2023-12-31 $2,633,365 182,619
2023-09-30 $173,600 10,000
2023-06-30 $273,651 13,150
2023-06-30 $728,350 35,000
2022-12-31 $777,459 27,836
2022-09-30 $2,888,238 123,429
2022-06-30 $10,404,348 308,277
2022-03-31 $244,510 7,000
2022-03-31 $7,204,452 206,254
2021-12-31 $1,639,732 53,850
2021-12-31 $26,281,790 863,113
2021-12-31 $213,759 7,020
2021-09-30 $1,798,531 54,850
2021-09-30 $25,806,089 787,011
2021-09-30 $230,185 7,020
2021-06-30 $2,809,641 92,850
2021-06-30 $212,425 7,020
2021-06-30 $34,631,540 1,144,466